Advances in Multiple Sclerosis Research-Series I

• Autore: Matsoukas John
• Pubblicazione: Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
• Descrizione fisica: 1 online resource (334 p.)
• Soggetto topico: Medicine
• Soggetto non controllato: adult-onset; agonist peptide; alemtuzumab; altered peptide ligands; antibodies against GluR3 peptide; antibody detection; antigen-specific immunotherapies; antigen-specific immunotherapy; astrocytes; autoimmune diseases; autoimmune encephalitis; autoimmunity; B cell receptor; biomarker; bupropion; carriers; cellular immunity; central nervous system; cerebral blood flow; chloroquine; clinical outcome; clinical outcomes; clinical phenotype; cognitive impairment; conformational analysis; conjugation; cranial nerve-VI palsy; craniopharyngioma; delivery methods; dendritic cells; diagnosis; diagnostic markers; disease-modifying treatments; drug delivery nanosystems; EAE; early-onset; ELISA; experimental autoimmune encephalomyelitis; fampridine; fractionated stereotactic radiation treatments; free light chains; Graphite/SiO2 electrode; gut microbiome; gut-brain axis; HPLC; Human Leucocyte Antigens; immune modulation; immune thrombocytopenic purpura; immunogenetics; immunoglobulins; immunomodulation; immunotherapeutics; immunotherapy; inflammation; intracortical facilitation; kappa; lipids; major depression; mannan; MBP83-99 peptide; memory T cells; metagenomics; microglia; MOG35-55; molecular dynamic; monoclonal antibodies; MS; MS drugs; multiple sclerosis; Multiple Sclerosis; multivalency; myelin basic protei; myelin oligodendrocyte glycoprotein; myelin peptides; N-glucosylated peptide epitopes; nanoparticles; nanotechnology; neurodegeneration; neuroimaging; neuropsychological assessment; NMR spectroscopy; NOE-constraints; oligodendrocytes; oxidative; peptide; peptides; plasma exchange; polymers; positron emission tomography; probiotics; proteolipid protein; S-adenosylmethionine; sample size; short intracortical inhibition; sphenoid sinusitis; ST285; Streptococcus thermophilus; T cell receptor; tDCS; tetraspanins; therapeutics; tolerance; tolerance induction; tolerogenic vaccines; trimolecular complex; TSPAN32; vaccine; vaccines; vitamin D3; voltammetry; walking disability; yoga
• Persona (resp. second.): ApostolopoulosVasso; MatsoukasJohn
• Sommario/riassunto: Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials.
• Titolo autorizzato: Advances in Multiple Sclerosis Research-Series I
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910557385403321
• Lo trovi qui: Univ. Federico II